Literature DB >> 27594176

Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme.

Nadia Aissaoui1, Etienne Puymirat1, Yves Juilliere2, Patrick Jourdain3, Didier Blanchard4, François Schiele5, Pascal Guéret6, Batric Popovic2, Jean Ferrieres7, Tabassome Simon8, Nicolas Danchin1.   

Abstract

AIMS: Alhough cardiogenic shock (CS) after acute myocardial infarction (AMI) is more common in elderly patients, information on the epidemiology of these patients is scarce. This study aimed to assess the trends in prevalence, characteristics, management, and outcomes of elderly patients admitted with CS complicating AMI between 1995 and 2010, using data from the FAST-MI programme. METHODS AND
RESULTS: We analysed the incidence and 1-year mortality of CS in four nationwide French surveys carried out 5 years apart from 1995 to 2010, including consecutive AMI patients over 1-month periods. Among the 10 610 patients, 3389 were aged ≥75 years, of whom 9.9% developed CS. The prevalence of CS decreased in elderly patients from 11.6% in 1995 to 6.7% in 2010 (P = 0.02). Over the 15-year period, the characteristics of elderly patients with CS changed, with more diabetes, hypertension, and hypercholesterolaemia. The use of PCI increased markedly in elderly patients with and without CS, reaching 51% and 59%, respectively, in 2010. In addition, medical therapy also evolved, with more patients receiving antithrombotic agents, beta-blockers, and statins. Over time, 1-year mortality decreased by 32% among elderly patients with CS but remained high (59% in 2010). ST-segmet elevation myocardial infarction and previous AMI were independent correlates of increased 1-year death, while study period was associated with decreased mortality (2010 vs, 1995: hazard ratio 0.40, 95% confidence interval 0.27-0.61, P < 0.001), along with early use of PCI.
CONCLUSION: Cardiogenic shock in elderly patients with AMI remains a major clinical concern. However, 1-year mortality declined in these patients, a decrease potentially mediated by broader use of PCI and the improvement of global patient management.
© 2016 The Authors. European Journal of Heart Failure © 2016 European Society of Cardiology.

Entities:  

Keywords:  Cardiogenic shock; Elderly; Epidemiology; Myocardial infarction; Percutaneous coronary intervention

Mesh:

Substances:

Year:  2016        PMID: 27594176     DOI: 10.1002/ejhf.585

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  7 in total

Review 1.  [Cardiogenic shock : Current evidence].

Authors:  H Thiele
Journal:  Herz       Date:  2017-12       Impact factor: 1.443

2.  Diabetes mellitus, revascularization and outcomes in elderly patients with myocardial infarction-related cardiogenic shock.

Authors:  Miquel Gual; Ariza Albert-Solé; Marí Garcaí Maárquez; Cristina Fernández; José L Bernal; Francesc Formiga; María-Isabel Barrionuevo; José C Sánchez-Salado; Victòria Lorente; Júlia Pascual; Isaac Llaó; Oriol Alegre; Angel Cequier; Javier Elola
Journal:  J Geriatr Cardiol       Date:  2020-10-28       Impact factor: 3.327

3.  Machine Learning for Prediction of Outcomes in Cardiogenic Shock.

Authors:  Fangning Rong; Huaqiang Xiang; Lu Qian; Yangjing Xue; Kangting Ji; Ripen Yin
Journal:  Front Cardiovasc Med       Date:  2022-05-06

4.  Fibrinolysis vs. primary percutaneous coronary intervention for ST-segment elevation myocardial infarction cardiogenic shock.

Authors:  Saraschandra Vallabhajosyula; Dhiran Verghese; Malcolm R Bell; Dennis H Murphree; Wisit Cheungpasitporn; Paul Elliott Miller; Shannon M Dunlay; Abhiram Prasad; Gurpreet S Sandhu; Rajiv Gulati; Mandeep Singh; Amir Lerman; Bernard J Gersh; David R Holmes; Gregory W Barsness
Journal:  ESC Heart Fail       Date:  2021-03-11

5.  Trends in the management and outcomes of patients admitted with acute coronary syndrome complicated by cardiogenic shock over the past decade: Real world data from the acute coronary syndrome Israeli survey (ACSIS).

Authors:  Eran Kalmanovich; Alex Blatt; Svetlana Brener; Meital Shlezinger; Nir Shlomo; Zvi Vered; Hanoch Hod; Ilan Goldenberg; Gabby Elbaz-Greener
Journal:  Oncotarget       Date:  2017-06-27

6.  Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non-Left Ventricular Assist Device Centers.

Authors:  Joseph I Wang; Daniel Y Lu; Dmitriy N Feldman; Stephen A McCullough; Parag Goyal; Maria G Karas; Irina Sobol; Evelyn M Horn; Luke K Kim; Udhay Krishnan
Journal:  J Am Heart Assoc       Date:  2020-11-23       Impact factor: 5.501

7.  Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study.

Authors:  Mari Hongisto; Johan Lassus; Tuukka Tarvasmäki; Alessandro Sionis; Jordi Sans-Rosello; Heli Tolppanen; Anu Kataja; Toni Jäntti; Tuija Sabell; Matias Greve Lindholm; Marek Banaszewski; Jose Silva Cardoso; John Parissis; Salvatore Di Somma; Valentina Carubelli; Raija Jurkko; Josep Masip; Veli-Pekka Harjola
Journal:  ESC Heart Fail       Date:  2021-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.